nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromazepam—CYP2E1—Fingolimod—multiple sclerosis	0.163	0.299	CbGbCtD
Bromazepam—CYP2E1—Mitoxantrone—multiple sclerosis	0.0767	0.141	CbGbCtD
Bromazepam—CYP3A4—Fingolimod—multiple sclerosis	0.0494	0.0906	CbGbCtD
Bromazepam—CYP2C19—Prednisone—multiple sclerosis	0.0399	0.0732	CbGbCtD
Bromazepam—CYP2E1—Dexamethasone—multiple sclerosis	0.0398	0.0729	CbGbCtD
Bromazepam—CYP3A4—Methylprednisolone—multiple sclerosis	0.0319	0.0584	CbGbCtD
Bromazepam—CYP2C19—Dexamethasone—multiple sclerosis	0.0249	0.0457	CbGbCtD
Bromazepam—CYP3A4—Triamcinolone—multiple sclerosis	0.0241	0.0442	CbGbCtD
Bromazepam—CYP3A4—Mitoxantrone—multiple sclerosis	0.0232	0.0426	CbGbCtD
Bromazepam—CYP3A4—Betamethasone—multiple sclerosis	0.0207	0.038	CbGbCtD
Bromazepam—CYP3A4—Prednisolone—multiple sclerosis	0.0204	0.0375	CbGbCtD
Bromazepam—CYP3A4—Prednisone—multiple sclerosis	0.0193	0.0354	CbGbCtD
Bromazepam—GABRR3—peripheral nervous system—multiple sclerosis	0.0139	0.0615	CbGeAlD
Bromazepam—CYP3A4—Dexamethasone—multiple sclerosis	0.012	0.0221	CbGbCtD
Bromazepam—GABRR2—peripheral nervous system—multiple sclerosis	0.012	0.0533	CbGeAlD
Bromazepam—GABRR1—peripheral nervous system—multiple sclerosis	0.0116	0.0513	CbGeAlD
Bromazepam—GABRR3—nerve—multiple sclerosis	0.0108	0.048	CbGeAlD
Bromazepam—GABRQ—nerve—multiple sclerosis	0.0108	0.048	CbGeAlD
Bromazepam—GABRR2—nerve—multiple sclerosis	0.00939	0.0416	CbGeAlD
Bromazepam—GABRR1—nerve—multiple sclerosis	0.00904	0.04	CbGeAlD
Bromazepam—GABRR3—retina—multiple sclerosis	0.00448	0.0199	CbGeAlD
Bromazepam—GABRR2—retina—multiple sclerosis	0.00389	0.0172	CbGeAlD
Bromazepam—GABRR1—retina—multiple sclerosis	0.00374	0.0166	CbGeAlD
Bromazepam—GABRA6—brainstem—multiple sclerosis	0.00323	0.0143	CbGeAlD
Bromazepam—GABRQ—nervous system—multiple sclerosis	0.00244	0.0108	CbGeAlD
Bromazepam—GABRR3—nervous system—multiple sclerosis	0.00244	0.0108	CbGeAlD
Bromazepam—GABRB2—brainstem—multiple sclerosis	0.00238	0.0105	CbGeAlD
Bromazepam—GABRD—medulla oblongata—multiple sclerosis	0.00235	0.0104	CbGeAlD
Bromazepam—GABRQ—central nervous system—multiple sclerosis	0.00234	0.0104	CbGeAlD
Bromazepam—GABRG1—medulla oblongata—multiple sclerosis	0.00226	0.01	CbGeAlD
Bromazepam—GABRB1—medulla oblongata—multiple sclerosis	0.00219	0.00972	CbGeAlD
Bromazepam—GABRA2—brainstem—multiple sclerosis	0.00217	0.00961	CbGeAlD
Bromazepam—GABRD—midbrain—multiple sclerosis	0.00215	0.00952	CbGeAlD
Bromazepam—GABRG3—nervous system—multiple sclerosis	0.00213	0.00945	CbGeAlD
Bromazepam—GABRR2—nervous system—multiple sclerosis	0.00211	0.00935	CbGeAlD
Bromazepam—GABRA1—brainstem—multiple sclerosis	0.0021	0.00929	CbGeAlD
Bromazepam—GABRG1—midbrain—multiple sclerosis	0.00207	0.00916	CbGeAlD
Bromazepam—GABRG3—central nervous system—multiple sclerosis	0.00205	0.00909	CbGeAlD
Bromazepam—GABRR1—nervous system—multiple sclerosis	0.00203	0.009	CbGeAlD
Bromazepam—GABRG1—spinal cord—multiple sclerosis	0.00202	0.00894	CbGeAlD
Bromazepam—GABRB1—midbrain—multiple sclerosis	0.00201	0.00888	CbGeAlD
Bromazepam—GABRR2—cerebellum—multiple sclerosis	0.00199	0.0088	CbGeAlD
Bromazepam—GABRR1—central nervous system—multiple sclerosis	0.00196	0.00867	CbGeAlD
Bromazepam—GABRB1—spinal cord—multiple sclerosis	0.00196	0.00867	CbGeAlD
Bromazepam—GABRQ—brain—multiple sclerosis	0.00186	0.00824	CbGeAlD
Bromazepam—GABRD—nervous system—multiple sclerosis	0.00177	0.00782	CbGeAlD
Bromazepam—GABRD—central nervous system—multiple sclerosis	0.0017	0.00753	CbGeAlD
Bromazepam—GABRG1—nervous system—multiple sclerosis	0.0017	0.00753	CbGeAlD
Bromazepam—GABRA6—nervous system—multiple sclerosis	0.00169	0.00749	CbGeAlD
Bromazepam—GABRD—cerebellum—multiple sclerosis	0.00166	0.00736	CbGeAlD
Bromazepam—GABRG2—medulla oblongata—multiple sclerosis	0.00166	0.00734	CbGeAlD
Bromazepam—GABRB2—medulla oblongata—multiple sclerosis	0.00166	0.00734	CbGeAlD
Bromazepam—GABRB1—nervous system—multiple sclerosis	0.00165	0.0073	CbGeAlD
Bromazepam—Fatigue—Fingolimod—multiple sclerosis	0.00164	0.00733	CcSEcCtD
Bromazepam—GABRA5—nervous system—multiple sclerosis	0.00164	0.00726	CbGeAlD
Bromazepam—GABRG1—central nervous system—multiple sclerosis	0.00164	0.00725	CbGeAlD
Bromazepam—GABRG3—brain—multiple sclerosis	0.00163	0.00722	CbGeAlD
Bromazepam—GABRA6—central nervous system—multiple sclerosis	0.00163	0.00721	CbGeAlD
Bromazepam—GABRG1—cerebellum—multiple sclerosis	0.0016	0.00709	CbGeAlD
Bromazepam—GABRA6—cerebellum—multiple sclerosis	0.00159	0.00704	CbGeAlD
Bromazepam—GABRB1—central nervous system—multiple sclerosis	0.00159	0.00703	CbGeAlD
Bromazepam—GABRA5—central nervous system—multiple sclerosis	0.00158	0.00699	CbGeAlD
Bromazepam—GABRR1—brain—multiple sclerosis	0.00155	0.00688	CbGeAlD
Bromazepam—GABRB1—cerebellum—multiple sclerosis	0.00155	0.00687	CbGeAlD
Bromazepam—GABRA3—nervous system—multiple sclerosis	0.00153	0.00676	CbGeAlD
Bromazepam—GABRG2—midbrain—multiple sclerosis	0.00151	0.0067	CbGeAlD
Bromazepam—GABRB2—midbrain—multiple sclerosis	0.00151	0.0067	CbGeAlD
Bromazepam—Connective tissue disorder—Cladribine—multiple sclerosis	0.00149	0.00666	CcSEcCtD
Bromazepam—GABRA4—nervous system—multiple sclerosis	0.00149	0.00659	CbGeAlD
Bromazepam—Cardiac failure—Mitoxantrone—multiple sclerosis	0.00148	0.0066	CcSEcCtD
Bromazepam—GABRG2—spinal cord—multiple sclerosis	0.00148	0.00654	CbGeAlD
Bromazepam—GABRB2—spinal cord—multiple sclerosis	0.00148	0.00654	CbGeAlD
Bromazepam—GABRA3—central nervous system—multiple sclerosis	0.00147	0.00651	CbGeAlD
Bromazepam—GABRA1—medulla oblongata—multiple sclerosis	0.00146	0.00648	CbGeAlD
Bromazepam—GABRA4—central nervous system—multiple sclerosis	0.00143	0.00634	CbGeAlD
Bromazepam—Eye disorder—Cladribine—multiple sclerosis	0.00142	0.00634	CcSEcCtD
Bromazepam—Cardiac disorder—Cladribine—multiple sclerosis	0.00141	0.00629	CcSEcCtD
Bromazepam—Euphoric mood—Prednisolone—multiple sclerosis	0.0014	0.00626	CcSEcCtD
Bromazepam—GABRA4—cerebellum—multiple sclerosis	0.0014	0.0062	CbGeAlD
Bromazepam—Asthenia—Fingolimod—multiple sclerosis	0.00137	0.0061	CcSEcCtD
Bromazepam—GABRD—brain—multiple sclerosis	0.00135	0.00598	CbGeAlD
Bromazepam—Pruritus—Fingolimod—multiple sclerosis	0.00135	0.00601	CcSEcCtD
Bromazepam—GABRA1—midbrain—multiple sclerosis	0.00134	0.00592	CbGeAlD
Bromazepam—Mental disorder—Cladribine—multiple sclerosis	0.00133	0.00594	CcSEcCtD
Bromazepam—Malnutrition—Cladribine—multiple sclerosis	0.00132	0.0059	CcSEcCtD
Bromazepam—GABRA1—spinal cord—multiple sclerosis	0.0013	0.00578	CbGeAlD
Bromazepam—GABRG1—brain—multiple sclerosis	0.0013	0.00576	CbGeAlD
Bromazepam—GABRA6—brain—multiple sclerosis	0.00129	0.00572	CbGeAlD
Bromazepam—Euphoric mood—Triamcinolone—multiple sclerosis	0.00129	0.00575	CcSEcCtD
Bromazepam—Euphoric mood—Methylprednisolone—multiple sclerosis	0.00129	0.00574	CcSEcCtD
Bromazepam—GABRB3—medulla oblongata—multiple sclerosis	0.00127	0.00563	CbGeAlD
Bromazepam—GABRB1—brain—multiple sclerosis	0.00126	0.00558	CbGeAlD
Bromazepam—Dizziness—Fingolimod—multiple sclerosis	0.00126	0.00562	CcSEcCtD
Bromazepam—GABRA5—brain—multiple sclerosis	0.00125	0.00555	CbGeAlD
Bromazepam—GABRG2—nervous system—multiple sclerosis	0.00124	0.00551	CbGeAlD
Bromazepam—GABRB2—nervous system—multiple sclerosis	0.00124	0.00551	CbGeAlD
Bromazepam—GABRB2—central nervous system—multiple sclerosis	0.0012	0.00531	CbGeAlD
Bromazepam—GABRG2—central nervous system—multiple sclerosis	0.0012	0.00531	CbGeAlD
Bromazepam—Headache—Fingolimod—multiple sclerosis	0.00119	0.00532	CcSEcCtD
Bromazepam—GABRB2—cerebellum—multiple sclerosis	0.00117	0.00519	CbGeAlD
Bromazepam—GABRG2—cerebellum—multiple sclerosis	0.00117	0.00519	CbGeAlD
Bromazepam—Euphoric mood—Betamethasone—multiple sclerosis	0.00117	0.00522	CcSEcCtD
Bromazepam—Euphoric mood—Dexamethasone—multiple sclerosis	0.00117	0.00522	CcSEcCtD
Bromazepam—GABRA3—brain—multiple sclerosis	0.00117	0.00517	CbGeAlD
Bromazepam—GABRB3—midbrain—multiple sclerosis	0.00116	0.00515	CbGeAlD
Bromazepam—Speech disorder—Methotrexate—multiple sclerosis	0.00115	0.00514	CcSEcCtD
Bromazepam—GABRA4—brain—multiple sclerosis	0.00114	0.00504	CbGeAlD
Bromazepam—GABRA2—nervous system—multiple sclerosis	0.00114	0.00504	CbGeAlD
Bromazepam—GABRB3—spinal cord—multiple sclerosis	0.00113	0.00502	CbGeAlD
Bromazepam—GABRE—nervous system—multiple sclerosis	0.00113	0.00499	CbGeAlD
Bromazepam—Cardiac arrest—Prednisolone—multiple sclerosis	0.00113	0.00503	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00112	0.00499	CcSEcCtD
Bromazepam—Cardiac failure—Methylprednisolone—multiple sclerosis	0.00111	0.00497	CcSEcCtD
Bromazepam—Drowsiness—Mitoxantrone—multiple sclerosis	0.00111	0.00496	CcSEcCtD
Bromazepam—GABRA1—nervous system—multiple sclerosis	0.0011	0.00487	CbGeAlD
Bromazepam—GABRA2—central nervous system—multiple sclerosis	0.00109	0.00485	CbGeAlD
Bromazepam—Confusional state—Cladribine—multiple sclerosis	0.00109	0.00486	CcSEcCtD
Bromazepam—GABRE—central nervous system—multiple sclerosis	0.00109	0.00481	CbGeAlD
Bromazepam—GABRA2—cerebellum—multiple sclerosis	0.00107	0.00474	CbGeAlD
Bromazepam—Psychotic disorder—Methylprednisolone—multiple sclerosis	0.00106	0.00474	CcSEcCtD
Bromazepam—GABRA1—central nervous system—multiple sclerosis	0.00106	0.00469	CbGeAlD
Bromazepam—Nervous system disorder—Cladribine—multiple sclerosis	0.00106	0.00472	CcSEcCtD
Bromazepam—Tachycardia—Cladribine—multiple sclerosis	0.00105	0.0047	CcSEcCtD
Bromazepam—Skin disorder—Cladribine—multiple sclerosis	0.00105	0.00468	CcSEcCtD
Bromazepam—Muscular weakness—Prednisolone—multiple sclerosis	0.00104	0.00466	CcSEcCtD
Bromazepam—Irritability—Methylprednisolone—multiple sclerosis	0.00104	0.00463	CcSEcCtD
Bromazepam—Cardiac arrest—Triamcinolone—multiple sclerosis	0.00103	0.00462	CcSEcCtD
Bromazepam—GABRA1—cerebellum—multiple sclerosis	0.00103	0.00458	CbGeAlD
Bromazepam—Cardiac arrest—Methylprednisolone—multiple sclerosis	0.00103	0.00461	CcSEcCtD
Bromazepam—Anorexia—Cladribine—multiple sclerosis	0.00103	0.00459	CcSEcCtD
Bromazepam—Euphoric mood—Prednisone—multiple sclerosis	0.00102	0.00455	CcSEcCtD
Bromazepam—Cardiac failure—Dexamethasone—multiple sclerosis	0.00101	0.00452	CcSEcCtD
Bromazepam—Cardiac failure—Betamethasone—multiple sclerosis	0.00101	0.00452	CcSEcCtD
Bromazepam—Hypotension—Cladribine—multiple sclerosis	0.00101	0.0045	CcSEcCtD
Bromazepam—Psychotic disorder—Betamethasone—multiple sclerosis	0.000964	0.00431	CcSEcCtD
Bromazepam—Psychotic disorder—Dexamethasone—multiple sclerosis	0.000964	0.00431	CcSEcCtD
Bromazepam—Muscular weakness—Triamcinolone—multiple sclerosis	0.00096	0.00429	CcSEcCtD
Bromazepam—Somnolence—Cladribine—multiple sclerosis	0.000959	0.00428	CcSEcCtD
Bromazepam—Muscular weakness—Methylprednisolone—multiple sclerosis	0.000958	0.00428	CcSEcCtD
Bromazepam—Depressed level of consciousness—Methotrexate—multiple sclerosis	0.000956	0.00427	CcSEcCtD
Bromazepam—GABRB3—nervous system—multiple sclerosis	0.000956	0.00423	CbGeAlD
Bromazepam—GABRG2—brain—multiple sclerosis	0.000951	0.00421	CbGeAlD
Bromazepam—GABRB2—brain—multiple sclerosis	0.000951	0.00421	CbGeAlD
Bromazepam—Irritability—Betamethasone—multiple sclerosis	0.000942	0.00421	CcSEcCtD
Bromazepam—Irritability—Dexamethasone—multiple sclerosis	0.000942	0.00421	CcSEcCtD
Bromazepam—Cardiac arrest—Betamethasone—multiple sclerosis	0.000939	0.00419	CcSEcCtD
Bromazepam—Cardiac arrest—Dexamethasone—multiple sclerosis	0.000939	0.00419	CcSEcCtD
Bromazepam—Decreased appetite—Cladribine—multiple sclerosis	0.000938	0.00419	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000931	0.00416	CcSEcCtD
Bromazepam—Fatigue—Cladribine—multiple sclerosis	0.00093	0.00415	CcSEcCtD
Bromazepam—GABRB3—central nervous system—multiple sclerosis	0.00092	0.00407	CbGeAlD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000909	0.00406	CcSEcCtD
Bromazepam—GABRB3—cerebellum—multiple sclerosis	0.000899	0.00398	CbGeAlD
Bromazepam—Feeling abnormal—Cladribine—multiple sclerosis	0.000889	0.00397	CcSEcCtD
Bromazepam—Cardiac failure—Prednisone—multiple sclerosis	0.000881	0.00394	CcSEcCtD
Bromazepam—Muscular weakness—Betamethasone—multiple sclerosis	0.000871	0.00389	CcSEcCtD
Bromazepam—Muscular weakness—Dexamethasone—multiple sclerosis	0.000871	0.00389	CcSEcCtD
Bromazepam—GABRA2—brain—multiple sclerosis	0.000869	0.00385	CbGeAlD
Bromazepam—GABRE—brain—multiple sclerosis	0.000862	0.00382	CbGeAlD
Bromazepam—Skin disorder—Azathioprine—multiple sclerosis	0.000852	0.0038	CcSEcCtD
Bromazepam—GABRA1—brain—multiple sclerosis	0.00084	0.00372	CbGeAlD
Bromazepam—Psychotic disorder—Prednisone—multiple sclerosis	0.00084	0.00375	CcSEcCtD
Bromazepam—Irritability—Prednisone—multiple sclerosis	0.000821	0.00367	CcSEcCtD
Bromazepam—Hypotension—Azathioprine—multiple sclerosis	0.000819	0.00366	CcSEcCtD
Bromazepam—Vision blurred—Mitoxantrone—multiple sclerosis	0.000819	0.00366	CcSEcCtD
Bromazepam—Cardiac arrest—Prednisone—multiple sclerosis	0.000818	0.00365	CcSEcCtD
Bromazepam—CYP2E1—medulla oblongata—multiple sclerosis	0.000809	0.00358	CbGeAlD
Bromazepam—Hypersensitivity—Cladribine—multiple sclerosis	0.000795	0.00355	CcSEcCtD
Bromazepam—Asthenia—Cladribine—multiple sclerosis	0.000774	0.00346	CcSEcCtD
Bromazepam—Pruritus—Cladribine—multiple sclerosis	0.000763	0.00341	CcSEcCtD
Bromazepam—Muscular weakness—Prednisone—multiple sclerosis	0.000758	0.00339	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000757	0.00338	CcSEcCtD
Bromazepam—Convulsion—Mitoxantrone—multiple sclerosis	0.000753	0.00336	CcSEcCtD
Bromazepam—Hallucination—Methylprednisolone—multiple sclerosis	0.000747	0.00334	CcSEcCtD
Bromazepam—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000738	0.0033	CcSEcCtD
Bromazepam—GABRB3—brain—multiple sclerosis	0.000731	0.00324	CbGeAlD
Bromazepam—Feeling abnormal—Azathioprine—multiple sclerosis	0.000723	0.00323	CcSEcCtD
Bromazepam—CYP2E1—spinal cord—multiple sclerosis	0.000722	0.0032	CbGeAlD
Bromazepam—Confusional state—Mitoxantrone—multiple sclerosis	0.000715	0.00319	CcSEcCtD
Bromazepam—Dizziness—Cladribine—multiple sclerosis	0.000713	0.00319	CcSEcCtD
Bromazepam—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000709	0.00317	CcSEcCtD
Bromazepam—Eye disorder—Methylprednisolone—multiple sclerosis	0.000702	0.00314	CcSEcCtD
Bromazepam—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000697	0.00311	CcSEcCtD
Bromazepam—Tachycardia—Mitoxantrone—multiple sclerosis	0.000692	0.00309	CcSEcCtD
Bromazepam—Skin disorder—Mitoxantrone—multiple sclerosis	0.000689	0.00308	CcSEcCtD
Bromazepam—Irritability—Methotrexate—multiple sclerosis	0.000686	0.00306	CcSEcCtD
Bromazepam—Vomiting—Cladribine—multiple sclerosis	0.000686	0.00306	CcSEcCtD
Bromazepam—Rash—Cladribine—multiple sclerosis	0.00068	0.00304	CcSEcCtD
Bromazepam—Hallucination—Dexamethasone—multiple sclerosis	0.00068	0.00304	CcSEcCtD
Bromazepam—Hallucination—Betamethasone—multiple sclerosis	0.00068	0.00304	CcSEcCtD
Bromazepam—Dermatitis—Cladribine—multiple sclerosis	0.000679	0.00303	CcSEcCtD
Bromazepam—Anorexia—Mitoxantrone—multiple sclerosis	0.000676	0.00302	CcSEcCtD
Bromazepam—Ataxia—Methotrexate—multiple sclerosis	0.000676	0.00302	CcSEcCtD
Bromazepam—Headache—Cladribine—multiple sclerosis	0.000676	0.00302	CcSEcCtD
Bromazepam—Vision blurred—Prednisolone—multiple sclerosis	0.000672	0.003	CcSEcCtD
Bromazepam—Hypotension—Mitoxantrone—multiple sclerosis	0.000662	0.00296	CcSEcCtD
Bromazepam—Mental disorder—Methylprednisolone—multiple sclerosis	0.000658	0.00294	CcSEcCtD
Bromazepam—Malnutrition—Methylprednisolone—multiple sclerosis	0.000654	0.00292	CcSEcCtD
Bromazepam—Hypersensitivity—Azathioprine—multiple sclerosis	0.000646	0.00289	CcSEcCtD
Bromazepam—Nausea—Cladribine—multiple sclerosis	0.000641	0.00286	CcSEcCtD
Bromazepam—Eye disorder—Dexamethasone—multiple sclerosis	0.000638	0.00285	CcSEcCtD
Bromazepam—Eye disorder—Betamethasone—multiple sclerosis	0.000638	0.00285	CcSEcCtD
Bromazepam—Somnolence—Mitoxantrone—multiple sclerosis	0.00063	0.00281	CcSEcCtD
Bromazepam—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000624	0.00279	CcSEcCtD
Bromazepam—Convulsion—Prednisolone—multiple sclerosis	0.000617	0.00276	CcSEcCtD
Bromazepam—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000616	0.00275	CcSEcCtD
Bromazepam—Fatigue—Mitoxantrone—multiple sclerosis	0.000611	0.00273	CcSEcCtD
Bromazepam—CYP2E1—nervous system—multiple sclerosis	0.000608	0.00269	CbGeAlD
Bromazepam—Hallucination—Prednisone—multiple sclerosis	0.000592	0.00264	CcSEcCtD
Bromazepam—CYP2E1—central nervous system—multiple sclerosis	0.000585	0.00259	CbGeAlD
Bromazepam—Connective tissue disorder—Prednisone—multiple sclerosis	0.000585	0.00261	CcSEcCtD
Bromazepam—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000584	0.00261	CcSEcCtD
Bromazepam—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000582	0.0026	CcSEcCtD
Bromazepam—Dizziness—Azathioprine—multiple sclerosis	0.00058	0.00259	CcSEcCtD
Bromazepam—CYP2E1—cerebellum—multiple sclerosis	0.000572	0.00253	CbGeAlD
Bromazepam—Convulsion—Triamcinolone—multiple sclerosis	0.000568	0.00254	CcSEcCtD
Bromazepam—Tachycardia—Prednisolone—multiple sclerosis	0.000568	0.00254	CcSEcCtD
Bromazepam—Convulsion—Methylprednisolone—multiple sclerosis	0.000567	0.00253	CcSEcCtD
Bromazepam—Vomiting—Azathioprine—multiple sclerosis	0.000558	0.00249	CcSEcCtD
Bromazepam—Eye disorder—Prednisone—multiple sclerosis	0.000556	0.00248	CcSEcCtD
Bromazepam—Drowsiness—Methotrexate—multiple sclerosis	0.000554	0.00247	CcSEcCtD
Bromazepam—Rash—Azathioprine—multiple sclerosis	0.000553	0.00247	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000553	0.00247	CcSEcCtD
Bromazepam—Dermatitis—Azathioprine—multiple sclerosis	0.000552	0.00247	CcSEcCtD
Bromazepam—Headache—Azathioprine—multiple sclerosis	0.000549	0.00245	CcSEcCtD
Bromazepam—Dry mouth—Triamcinolone—multiple sclerosis	0.000546	0.00244	CcSEcCtD
Bromazepam—Confusional state—Methylprednisolone—multiple sclerosis	0.000538	0.0024	CcSEcCtD
Bromazepam—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000535	0.00239	CcSEcCtD
Bromazepam—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000534	0.00238	CcSEcCtD
Bromazepam—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000523	0.00234	CcSEcCtD
Bromazepam—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000522	0.00233	CcSEcCtD
Bromazepam—Tachycardia—Triamcinolone—multiple sclerosis	0.000522	0.00233	CcSEcCtD
Bromazepam—Mental disorder—Prednisone—multiple sclerosis	0.000521	0.00233	CcSEcCtD
Bromazepam—Nausea—Azathioprine—multiple sclerosis	0.000521	0.00233	CcSEcCtD
Bromazepam—Tachycardia—Methylprednisolone—multiple sclerosis	0.000521	0.00233	CcSEcCtD
Bromazepam—Skin disorder—Methylprednisolone—multiple sclerosis	0.000518	0.00232	CcSEcCtD
Bromazepam—Malnutrition—Prednisone—multiple sclerosis	0.000518	0.00231	CcSEcCtD
Bromazepam—Convulsion—Betamethasone—multiple sclerosis	0.000515	0.0023	CcSEcCtD
Bromazepam—Convulsion—Dexamethasone—multiple sclerosis	0.000515	0.0023	CcSEcCtD
Bromazepam—Asthenia—Mitoxantrone—multiple sclerosis	0.000509	0.00227	CcSEcCtD
Bromazepam—Hypotension—Methylprednisolone—multiple sclerosis	0.000499	0.00223	CcSEcCtD
Bromazepam—CYP3A4—nervous system—multiple sclerosis	0.000489	0.00217	CbGeAlD
Bromazepam—Vision blurred—Prednisone—multiple sclerosis	0.000488	0.00218	CcSEcCtD
Bromazepam—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000485	0.00217	CcSEcCtD
Bromazepam—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000485	0.00217	CcSEcCtD
Bromazepam—Feeling abnormal—Prednisolone—multiple sclerosis	0.000479	0.00214	CcSEcCtD
Bromazepam—Nervous system disorder—Betamethasone—multiple sclerosis	0.000476	0.00213	CcSEcCtD
Bromazepam—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000476	0.00213	CcSEcCtD
Bromazepam—Agitation—Prednisone—multiple sclerosis	0.000476	0.00213	CcSEcCtD
Bromazepam—Tachycardia—Dexamethasone—multiple sclerosis	0.000474	0.00212	CcSEcCtD
Bromazepam—Tachycardia—Betamethasone—multiple sclerosis	0.000474	0.00212	CcSEcCtD
Bromazepam—CYP3A4—central nervous system—multiple sclerosis	0.000471	0.00209	CbGeAlD
Bromazepam—Dyspepsia—Triamcinolone—multiple sclerosis	0.000471	0.0021	CcSEcCtD
Bromazepam—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00047	0.0021	CcSEcCtD
Bromazepam—CYP2E1—brain—multiple sclerosis	0.000465	0.00206	CbGeAlD
Bromazepam—Eye disorder—Methotrexate—multiple sclerosis	0.000465	0.00208	CcSEcCtD
Bromazepam—Anorexia—Dexamethasone—multiple sclerosis	0.000463	0.00207	CcSEcCtD
Bromazepam—Anorexia—Betamethasone—multiple sclerosis	0.000463	0.00207	CcSEcCtD
Bromazepam—Cardiac disorder—Methotrexate—multiple sclerosis	0.000461	0.00206	CcSEcCtD
Bromazepam—Fatigue—Triamcinolone—multiple sclerosis	0.000461	0.00206	CcSEcCtD
Bromazepam—Fatigue—Methylprednisolone—multiple sclerosis	0.00046	0.00206	CcSEcCtD
Bromazepam—Hypotension—Dexamethasone—multiple sclerosis	0.000453	0.00203	CcSEcCtD
Bromazepam—Hypotension—Betamethasone—multiple sclerosis	0.000453	0.00203	CcSEcCtD
Bromazepam—Vomiting—Mitoxantrone—multiple sclerosis	0.000451	0.00201	CcSEcCtD
Bromazepam—Convulsion—Prednisone—multiple sclerosis	0.000449	0.002	CcSEcCtD
Bromazepam—Rash—Mitoxantrone—multiple sclerosis	0.000447	0.002	CcSEcCtD
Bromazepam—Dermatitis—Mitoxantrone—multiple sclerosis	0.000447	0.00199	CcSEcCtD
Bromazepam—Headache—Mitoxantrone—multiple sclerosis	0.000444	0.00198	CcSEcCtD
Bromazepam—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000441	0.00197	CcSEcCtD
Bromazepam—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00044	0.00196	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000438	0.00196	CcSEcCtD
Bromazepam—Mental disorder—Methotrexate—multiple sclerosis	0.000436	0.00195	CcSEcCtD
Bromazepam—Malnutrition—Methotrexate—multiple sclerosis	0.000433	0.00193	CcSEcCtD
Bromazepam—Hypersensitivity—Prednisolone—multiple sclerosis	0.000429	0.00191	CcSEcCtD
Bromazepam—Dyspepsia—Dexamethasone—multiple sclerosis	0.000427	0.00191	CcSEcCtD
Bromazepam—Dyspepsia—Betamethasone—multiple sclerosis	0.000427	0.00191	CcSEcCtD
Bromazepam—Anaphylactic shock—Prednisone—multiple sclerosis	0.000423	0.00189	CcSEcCtD
Bromazepam—Decreased appetite—Betamethasone—multiple sclerosis	0.000422	0.00188	CcSEcCtD
Bromazepam—Decreased appetite—Dexamethasone—multiple sclerosis	0.000422	0.00188	CcSEcCtD
Bromazepam—Nausea—Mitoxantrone—multiple sclerosis	0.000421	0.00188	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000419	0.00187	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000419	0.00187	CcSEcCtD
Bromazepam—Fatigue—Betamethasone—multiple sclerosis	0.000418	0.00187	CcSEcCtD
Bromazepam—Fatigue—Dexamethasone—multiple sclerosis	0.000418	0.00187	CcSEcCtD
Bromazepam—Nervous system disorder—Prednisone—multiple sclerosis	0.000414	0.00185	CcSEcCtD
Bromazepam—Tachycardia—Prednisone—multiple sclerosis	0.000412	0.00184	CcSEcCtD
Bromazepam—Skin disorder—Prednisone—multiple sclerosis	0.000411	0.00183	CcSEcCtD
Bromazepam—Vision blurred—Methotrexate—multiple sclerosis	0.000408	0.00182	CcSEcCtD
Bromazepam—Anorexia—Prednisone—multiple sclerosis	0.000403	0.0018	CcSEcCtD
Bromazepam—Feeling abnormal—Betamethasone—multiple sclerosis	0.0004	0.00179	CcSEcCtD
Bromazepam—Feeling abnormal—Dexamethasone—multiple sclerosis	0.0004	0.00179	CcSEcCtD
Bromazepam—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000394	0.00176	CcSEcCtD
Bromazepam—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000393	0.00176	CcSEcCtD
Bromazepam—Dizziness—Prednisolone—multiple sclerosis	0.000385	0.00172	CcSEcCtD
Bromazepam—Asthenia—Triamcinolone—multiple sclerosis	0.000384	0.00171	CcSEcCtD
Bromazepam—Asthenia—Methylprednisolone—multiple sclerosis	0.000383	0.00171	CcSEcCtD
Bromazepam—Pruritus—Triamcinolone—multiple sclerosis	0.000378	0.00169	CcSEcCtD
Bromazepam—Pruritus—Methylprednisolone—multiple sclerosis	0.000378	0.00169	CcSEcCtD
Bromazepam—Convulsion—Methotrexate—multiple sclerosis	0.000375	0.00167	CcSEcCtD
Bromazepam—Dyspepsia—Prednisone—multiple sclerosis	0.000372	0.00166	CcSEcCtD
Bromazepam—Decreased appetite—Prednisone—multiple sclerosis	0.000367	0.00164	CcSEcCtD
Bromazepam—Rash—Prednisolone—multiple sclerosis	0.000367	0.00164	CcSEcCtD
Bromazepam—Dermatitis—Prednisolone—multiple sclerosis	0.000366	0.00164	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000366	0.00163	CcSEcCtD
Bromazepam—Fatigue—Prednisone—multiple sclerosis	0.000364	0.00163	CcSEcCtD
Bromazepam—Headache—Prednisolone—multiple sclerosis	0.000364	0.00163	CcSEcCtD
Bromazepam—Confusional state—Methotrexate—multiple sclerosis	0.000356	0.00159	CcSEcCtD
Bromazepam—Dizziness—Triamcinolone—multiple sclerosis	0.000354	0.00158	CcSEcCtD
Bromazepam—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000353	0.00158	CcSEcCtD
Bromazepam—Dizziness—Methylprednisolone—multiple sclerosis	0.000353	0.00158	CcSEcCtD
Bromazepam—Feeling abnormal—Prednisone—multiple sclerosis	0.000348	0.00156	CcSEcCtD
Bromazepam—Asthenia—Dexamethasone—multiple sclerosis	0.000348	0.00156	CcSEcCtD
Bromazepam—Asthenia—Betamethasone—multiple sclerosis	0.000348	0.00156	CcSEcCtD
Bromazepam—Nervous system disorder—Methotrexate—multiple sclerosis	0.000346	0.00155	CcSEcCtD
Bromazepam—Nausea—Prednisolone—multiple sclerosis	0.000345	0.00154	CcSEcCtD
Bromazepam—Pruritus—Dexamethasone—multiple sclerosis	0.000343	0.00153	CcSEcCtD
Bromazepam—Pruritus—Betamethasone—multiple sclerosis	0.000343	0.00153	CcSEcCtD
Bromazepam—Skin disorder—Methotrexate—multiple sclerosis	0.000343	0.00153	CcSEcCtD
Bromazepam—Vomiting—Triamcinolone—multiple sclerosis	0.00034	0.00152	CcSEcCtD
Bromazepam—Vomiting—Methylprednisolone—multiple sclerosis	0.000339	0.00152	CcSEcCtD
Bromazepam—Rash—Triamcinolone—multiple sclerosis	0.000337	0.00151	CcSEcCtD
Bromazepam—Dermatitis—Triamcinolone—multiple sclerosis	0.000337	0.0015	CcSEcCtD
Bromazepam—Anorexia—Methotrexate—multiple sclerosis	0.000337	0.0015	CcSEcCtD
Bromazepam—Rash—Methylprednisolone—multiple sclerosis	0.000336	0.0015	CcSEcCtD
Bromazepam—Dermatitis—Methylprednisolone—multiple sclerosis	0.000336	0.0015	CcSEcCtD
Bromazepam—Headache—Triamcinolone—multiple sclerosis	0.000335	0.0015	CcSEcCtD
Bromazepam—Headache—Methylprednisolone—multiple sclerosis	0.000334	0.00149	CcSEcCtD
Bromazepam—Hypotension—Methotrexate—multiple sclerosis	0.00033	0.00147	CcSEcCtD
Bromazepam—Dizziness—Betamethasone—multiple sclerosis	0.000321	0.00143	CcSEcCtD
Bromazepam—Dizziness—Dexamethasone—multiple sclerosis	0.000321	0.00143	CcSEcCtD
Bromazepam—Nausea—Triamcinolone—multiple sclerosis	0.000318	0.00142	CcSEcCtD
Bromazepam—Nausea—Methylprednisolone—multiple sclerosis	0.000317	0.00142	CcSEcCtD
Bromazepam—Somnolence—Methotrexate—multiple sclerosis	0.000314	0.0014	CcSEcCtD
Bromazepam—Hypersensitivity—Prednisone—multiple sclerosis	0.000311	0.00139	CcSEcCtD
Bromazepam—Dyspepsia—Methotrexate—multiple sclerosis	0.000311	0.00139	CcSEcCtD
Bromazepam—Vomiting—Betamethasone—multiple sclerosis	0.000309	0.00138	CcSEcCtD
Bromazepam—Vomiting—Dexamethasone—multiple sclerosis	0.000309	0.00138	CcSEcCtD
Bromazepam—Decreased appetite—Methotrexate—multiple sclerosis	0.000307	0.00137	CcSEcCtD
Bromazepam—Rash—Dexamethasone—multiple sclerosis	0.000306	0.00137	CcSEcCtD
Bromazepam—Rash—Betamethasone—multiple sclerosis	0.000306	0.00137	CcSEcCtD
Bromazepam—Dermatitis—Dexamethasone—multiple sclerosis	0.000306	0.00137	CcSEcCtD
Bromazepam—Dermatitis—Betamethasone—multiple sclerosis	0.000306	0.00137	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000305	0.00136	CcSEcCtD
Bromazepam—Fatigue—Methotrexate—multiple sclerosis	0.000305	0.00136	CcSEcCtD
Bromazepam—Headache—Dexamethasone—multiple sclerosis	0.000304	0.00136	CcSEcCtD
Bromazepam—Headache—Betamethasone—multiple sclerosis	0.000304	0.00136	CcSEcCtD
Bromazepam—Asthenia—Prednisone—multiple sclerosis	0.000303	0.00135	CcSEcCtD
Bromazepam—Pruritus—Prednisone—multiple sclerosis	0.000299	0.00134	CcSEcCtD
Bromazepam—Feeling abnormal—Methotrexate—multiple sclerosis	0.000291	0.0013	CcSEcCtD
Bromazepam—Nausea—Dexamethasone—multiple sclerosis	0.000288	0.00129	CcSEcCtD
Bromazepam—Nausea—Betamethasone—multiple sclerosis	0.000288	0.00129	CcSEcCtD
Bromazepam—Dizziness—Prednisone—multiple sclerosis	0.000279	0.00125	CcSEcCtD
Bromazepam—Vomiting—Prednisone—multiple sclerosis	0.000269	0.0012	CcSEcCtD
Bromazepam—Rash—Prednisone—multiple sclerosis	0.000266	0.00119	CcSEcCtD
Bromazepam—Dermatitis—Prednisone—multiple sclerosis	0.000266	0.00119	CcSEcCtD
Bromazepam—Headache—Prednisone—multiple sclerosis	0.000265	0.00118	CcSEcCtD
Bromazepam—Hypersensitivity—Methotrexate—multiple sclerosis	0.00026	0.00116	CcSEcCtD
Bromazepam—Asthenia—Methotrexate—multiple sclerosis	0.000253	0.00113	CcSEcCtD
Bromazepam—Nausea—Prednisone—multiple sclerosis	0.000251	0.00112	CcSEcCtD
Bromazepam—Pruritus—Methotrexate—multiple sclerosis	0.00025	0.00112	CcSEcCtD
Bromazepam—Dizziness—Methotrexate—multiple sclerosis	0.000234	0.00104	CcSEcCtD
Bromazepam—Vomiting—Methotrexate—multiple sclerosis	0.000225	0.001	CcSEcCtD
Bromazepam—Rash—Methotrexate—multiple sclerosis	0.000223	0.000995	CcSEcCtD
Bromazepam—Dermatitis—Methotrexate—multiple sclerosis	0.000223	0.000994	CcSEcCtD
Bromazepam—Headache—Methotrexate—multiple sclerosis	0.000221	0.000988	CcSEcCtD
Bromazepam—Nausea—Methotrexate—multiple sclerosis	0.00021	0.000937	CcSEcCtD
Bromazepam—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	2.64e-05	0.00558	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.6e-05	0.0055	CbGpPWpGaD
Bromazepam—GABRR1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	2.56e-05	0.0054	CbGpPWpGaD
Bromazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	2.52e-05	0.00531	CbGpPWpGaD
Bromazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	2.52e-05	0.00531	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.48e-05	0.00524	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.48e-05	0.00524	CbGpPWpGaD
Bromazepam—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	2.48e-05	0.00524	CbGpPWpGaD
Bromazepam—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	2.48e-05	0.00524	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	2.44e-05	0.00516	CbGpPWpGaD
Bromazepam—GABRR2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	2.44e-05	0.00515	CbGpPWpGaD
Bromazepam—GABRQ—Transmission across Chemical Synapses—BCHE—multiple sclerosis	2.44e-05	0.00515	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—CYP24A1—multiple sclerosis	2.33e-05	0.00493	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—CYP27B1—multiple sclerosis	2.33e-05	0.00493	CbGpPWpGaD
Bromazepam—CYP2E1—Metapathway biotransformation—CYP27B1—multiple sclerosis	2.3e-05	0.00486	CbGpPWpGaD
Bromazepam—CYP2E1—Metapathway biotransformation—CYP24A1—multiple sclerosis	2.3e-05	0.00486	CbGpPWpGaD
Bromazepam—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	2.26e-05	0.00476	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.05e-05	0.00432	CbGpPWpGaD
Bromazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	2.04e-05	0.0043	CbGpPWpGaD
Bromazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	2.04e-05	0.0043	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.02e-05	0.00425	CbGpPWpGaD
Bromazepam—GABRG3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	2.01e-05	0.00424	CbGpPWpGaD
Bromazepam—GABRB1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	1.98e-05	0.00418	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.97e-05	0.00417	CbGpPWpGaD
Bromazepam—GABRR1—Neuronal System—BCHE—multiple sclerosis	1.96e-05	0.00414	CbGpPWpGaD
Bromazepam—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	1.96e-05	0.00414	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—CNR1—multiple sclerosis	1.94e-05	0.0041	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.91e-05	0.00403	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.88e-05	0.00397	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.88e-05	0.00397	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.88e-05	0.00397	CbGpPWpGaD
Bromazepam—GABRA6—Transmission across Chemical Synapses—BCHE—multiple sclerosis	1.87e-05	0.00395	CbGpPWpGaD
Bromazepam—GABRQ—Neuronal System—BCHE—multiple sclerosis	1.87e-05	0.00395	CbGpPWpGaD
Bromazepam—GABRR2—Neuronal System—BCHE—multiple sclerosis	1.87e-05	0.00395	CbGpPWpGaD
Bromazepam—GABRA4—Transmission across Chemical Synapses—BCHE—multiple sclerosis	1.85e-05	0.0039	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	1.8e-05	0.0038	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	1.8e-05	0.0038	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	1.78e-05	0.00375	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	1.78e-05	0.00375	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	1.75e-05	0.0037	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.72e-05	0.00364	CbGpPWpGaD
Bromazepam—GABRB2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	1.69e-05	0.00357	CbGpPWpGaD
Bromazepam—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	1.68e-05	0.00355	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.67e-05	0.00353	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—BCHE—multiple sclerosis	1.64e-05	0.00347	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.64e-05	0.00347	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.61e-05	0.00341	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	1.61e-05	0.00341	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.6e-05	0.00339	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	1.59e-05	0.00335	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	1.58e-05	0.00333	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.57e-05	0.00332	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—BDNF—multiple sclerosis	1.57e-05	0.00331	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.56e-05	0.00329	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.55e-05	0.00327	CbGpPWpGaD
Bromazepam—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	1.55e-05	0.00327	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	1.55e-05	0.00327	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—BCHE—multiple sclerosis	1.54e-05	0.00325	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.53e-05	0.00322	CbGpPWpGaD
Bromazepam—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	1.53e-05	0.00322	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—BCHE—multiple sclerosis	1.52e-05	0.0032	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.49e-05	0.00314	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.49e-05	0.00314	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.45e-05	0.00305	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—BCHE—multiple sclerosis	1.44e-05	0.00303	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.43e-05	0.00301	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—BCHE—multiple sclerosis	1.42e-05	0.00299	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	1.4e-05	0.00296	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	1.4e-05	0.00296	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—SPP1—multiple sclerosis	1.39e-05	0.00294	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	1.38e-05	0.00292	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	1.38e-05	0.00292	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.38e-05	0.00291	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.38e-05	0.00291	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	1.35e-05	0.00285	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.32e-05	0.00278	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.32e-05	0.00278	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.31e-05	0.00275	CbGpPWpGaD
Bromazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	1.3e-05	0.00274	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—BCHE—multiple sclerosis	1.3e-05	0.00274	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.27e-05	0.00268	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	1.26e-05	0.00267	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—BCHE—multiple sclerosis	1.26e-05	0.00266	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.25e-05	0.00263	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—BCHE—multiple sclerosis	1.24e-05	0.00261	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.23e-05	0.00259	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.22e-05	0.00258	CbGpPWpGaD
Bromazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.22e-05	0.00257	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.22e-05	0.00257	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—BCHE—multiple sclerosis	1.22e-05	0.00257	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.21e-05	0.00255	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—BCHE—multiple sclerosis	1.21e-05	0.00255	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	1.21e-05	0.00255	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.19e-05	0.00252	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—BCHE—multiple sclerosis	1.19e-05	0.0025	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.14e-05	0.00241	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.13e-05	0.00238	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.08e-05	0.00229	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	1.08e-05	0.00229	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	1.08e-05	0.00229	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	1.07e-05	0.00226	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	1.07e-05	0.00226	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.07e-05	0.00225	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.04e-05	0.0022	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—BCHE—multiple sclerosis	1.04e-05	0.00219	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.03e-05	0.00218	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.01e-05	0.00213	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1e-05	0.00212	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.97e-06	0.0021	CbGpPWpGaD
Bromazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	9.95e-06	0.0021	CbGpPWpGaD
Bromazepam—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.89e-06	0.00209	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.84e-06	0.00208	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.67e-06	0.00204	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.61e-06	0.00203	CbGpPWpGaD
Bromazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	9.49e-06	0.002	CbGpPWpGaD
Bromazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	9.49e-06	0.002	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.44e-06	0.00199	CbGpPWpGaD
Bromazepam—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.41e-06	0.00199	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.12e-06	0.00193	CbGpPWpGaD
Bromazepam—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	9e-06	0.0019	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.86e-06	0.00187	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.7e-06	0.00184	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.55e-06	0.0018	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.49e-06	0.00179	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.34e-06	0.00176	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.25e-06	0.00174	CbGpPWpGaD
Bromazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	7.81e-06	0.00165	CbGpPWpGaD
Bromazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	7.7e-06	0.00162	CbGpPWpGaD
Bromazepam—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.63e-06	0.00161	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	7.54e-06	0.00159	CbGpPWpGaD
Bromazepam—GABRR1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	7.48e-06	0.00158	CbGpPWpGaD
Bromazepam—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.33e-06	0.00155	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.29e-06	0.00154	CbGpPWpGaD
Bromazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	7.28e-06	0.00154	CbGpPWpGaD
Bromazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	7.19e-06	0.00152	CbGpPWpGaD
Bromazepam—GABRR2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	7.13e-06	0.00151	CbGpPWpGaD
Bromazepam—GABRQ—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	7.13e-06	0.00151	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.92e-06	0.00146	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.92e-06	0.00146	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	6.73e-06	0.00142	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	6.7e-06	0.00142	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—STAT3—multiple sclerosis	6.59e-06	0.00139	CbGpPWpGaD
Bromazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	6.58e-06	0.00139	CbGpPWpGaD
Bromazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	6.39e-06	0.00135	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	6.33e-06	0.00134	CbGpPWpGaD
Bromazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	6.27e-06	0.00132	CbGpPWpGaD
Bromazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	6.17e-06	0.0013	CbGpPWpGaD
Bromazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	6.13e-06	0.00129	CbGpPWpGaD
Bromazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	6.01e-06	0.00127	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—MAPK1—multiple sclerosis	5.99e-06	0.00126	CbGpPWpGaD
Bromazepam—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.94e-06	0.00125	CbGpPWpGaD
Bromazepam—GABRG3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.87e-06	0.00124	CbGpPWpGaD
Bromazepam—GABRB1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.79e-06	0.00122	CbGpPWpGaD
Bromazepam—GABRR1—Neuronal System—MAPK1—multiple sclerosis	5.73e-06	0.00121	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—SRM—multiple sclerosis	5.67e-06	0.0012	CbGpPWpGaD
Bromazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.66e-06	0.00119	CbGpPWpGaD
Bromazepam—GABRA6—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.47e-06	0.00116	CbGpPWpGaD
Bromazepam—GABRR2—Neuronal System—MAPK1—multiple sclerosis	5.46e-06	0.00115	CbGpPWpGaD
Bromazepam—GABRQ—Neuronal System—MAPK1—multiple sclerosis	5.46e-06	0.00115	CbGpPWpGaD
Bromazepam—GABRA4—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.41e-06	0.00114	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.39e-06	0.00114	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.39e-06	0.00114	CbGpPWpGaD
Bromazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	5.26e-06	0.00111	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—POMC—multiple sclerosis	5.25e-06	0.00111	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	5.24e-06	0.00111	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	5.23e-06	0.0011	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	5.13e-06	0.00108	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.97e-06	0.00105	CbGpPWpGaD
Bromazepam—GABRB2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.94e-06	0.00104	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	4.88e-06	0.00103	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.88e-06	0.00103	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.8e-06	0.00101	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.74e-06	0.001	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.74e-06	0.001	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.72e-06	0.000996	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.63e-06	0.000978	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.6e-06	0.000972	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	4.59e-06	0.000969	CbGpPWpGaD
Bromazepam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.59e-06	0.000968	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.52e-06	0.000954	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—MAPK1—multiple sclerosis	4.5e-06	0.00095	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—MAPK1—multiple sclerosis	4.43e-06	0.000936	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SRM—multiple sclerosis	4.37e-06	0.000923	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—MAPK1—multiple sclerosis	4.19e-06	0.000885	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—MAPK1—multiple sclerosis	4.14e-06	0.000874	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—POMC—multiple sclerosis	4.05e-06	0.000855	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	3.99e-06	0.000843	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	3.99e-06	0.000843	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.95e-06	0.000834	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.9e-06	0.000823	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.84e-06	0.000811	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—MAPK1—multiple sclerosis	3.79e-06	0.0008	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3.7e-06	0.000782	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—MAPK1—multiple sclerosis	3.68e-06	0.000777	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GPC5—multiple sclerosis	3.65e-06	0.000771	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.64e-06	0.000767	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—MAPK1—multiple sclerosis	3.61e-06	0.000763	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.59e-06	0.000758	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—MAPK1—multiple sclerosis	3.55e-06	0.00075	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—MAPK1—multiple sclerosis	3.53e-06	0.000745	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—MAPK1—multiple sclerosis	3.46e-06	0.000731	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SRM—multiple sclerosis	3.41e-06	0.000719	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.28e-06	0.000693	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.19e-06	0.000673	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—POMC—multiple sclerosis	3.16e-06	0.000666	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.13e-06	0.000661	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	3.08e-06	0.00065	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	3.08e-06	0.00065	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.08e-06	0.00065	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.06e-06	0.000646	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—MAPK1—multiple sclerosis	3.03e-06	0.000639	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—RRM1—multiple sclerosis	3.03e-06	0.000639	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.01e-06	0.000636	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3e-06	0.000634	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.82e-06	0.000595	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SRM—multiple sclerosis	2.63e-06	0.000555	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.62e-06	0.000554	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.44e-06	0.000514	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.4e-06	0.000507	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.4e-06	0.000507	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.35e-06	0.000495	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.33e-06	0.000493	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.2e-06	0.000463	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.85e-06	0.000391	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.85e-06	0.000391	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.82e-06	0.000384	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.81e-06	0.000382	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.74e-06	0.000367	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.69e-06	0.000358	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.56e-06	0.000328	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.42e-06	0.000299	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.41e-06	0.000298	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.4e-06	0.000296	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.34e-06	0.000283	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.21e-06	0.000256	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.11e-06	0.000233	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—APOE—multiple sclerosis	1.05e-06	0.000221	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.04e-06	0.000221	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—POMC—multiple sclerosis	8.98e-07	0.00019	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ALB—multiple sclerosis	8.19e-07	0.000173	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—APOE—multiple sclerosis	8.07e-07	0.00017	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—BCHE—multiple sclerosis	8.06e-07	0.00017	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—POMC—multiple sclerosis	6.93e-07	0.000146	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ALB—multiple sclerosis	6.32e-07	0.000133	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—APOE—multiple sclerosis	6.29e-07	0.000133	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—POMC—multiple sclerosis	5.4e-07	0.000114	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ALB—multiple sclerosis	4.92e-07	0.000104	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—APOE—multiple sclerosis	4.85e-07	0.000102	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—POMC—multiple sclerosis	4.17e-07	8.8e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ALB—multiple sclerosis	3.8e-07	8.02e-05	CbGpPWpGaD
